NOVEL CORONAVIRUS COVID-19 ELISA Kits
IgG, IgM & IgA

Providing test systems in high quality, accuracy, sensitivity & specificity. Due to our scalability we can output high production capacity, servicing the high demand for testing.

EMPOWERED
By Pioneering
AUTOMATION

procedures can be made more efficient as well as being objective. Therefore, the results are qualitatively and quantitatively always the same and can consequently be assessed more easily in terms of quality management.

Wide Variety Of
INNOVATIVE
IVD Products And
SOLUTIONS

makes Monocent Inc, the core provider of all laboratory needs globally. Envisioning a monocentric model for the industry, we strive to be the one and only center to offer a comprehensive array of superior test systems and compatible instruments.

EXTENSIVE
And Growing
Distribution
NETWORK

has been overwhelming, but we continue to provide our innovative products, customer service and technical support in over 50 countries to private institutions, academic/research sectors, laboratories and worldwide distributors.

MANUFACTURING
With
INTELLIGENCE
And Efficiency

increases performance and creates quality products with competitive pricing. Focused on lean production, using state of the art technology, Monocent inc. aims to deliver quality and excellence in research and diagnostics.

EVOLVING
Research
And
DEVELOPMENT

is one area that Monocent doesn’t hesitate to invest its resources. Creating and enhancing IVD products is a passion that drives our company.

IMMERSED
in Highest
Uncompromising
QUALITY

Monocent surpasses above and beyond regulatory QMS requirements and provides unforeseen superiority in IVD products.

previous arrow
next arrow
PlayPause
Slider

Monocent is a U.S-based IVD company and this is

What We Do

Development

Constant thirst for innovating new products and solutions in the field of diagnostics is embedded within our company’s DNA.

Manufacturing

Based on a strategic calculation of availability, performance and quality we ensure operational excellence and on-time delivery

Distribution

Having local familiarity with governments and regulations, contact networks and field experience, our international sales team is valuable resource for any distributor.

NOW AVAILABLE!!!

COVID-19 IgG/IgM RAPID TEST

Monocent, Inc. has launched and is offering COVID-19 Serological Rapid Test for the qualitative detection of IgM and IgG antibodies of the novel coronavirus  in human serum and whole blood.

Screening for COVID-19 IgM and IgG antibodies is a rapid and effective method for the diagnosis of COVID-19 infection. The IgM and IgG antibody test can also provide information on the stage of infection.

  • Results can be obtained as short as in 10-15 minutes with a simple finger prick sample.
  • Small sample volume with high sensitivity and specificity with results validated using PCR.
  • Our COVID-19 IgG/IgM rapid test device has an internal control, separate test lines for IgG and IgM..
  • This product is only sold to laboratory and health professionals. Not for home use or blood screening.
  • This product has CE-IVD registration and is sold and marketed in EU countries and worldwide.

We are distributing our COVID-19 Rapid Test kits in the United States under the provisions outlined in Section D of Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.

The demand is quite high for this product. Please submit your inquiry as soon as possible to fit your order through our production capacity and avoid delays.

ELISA

Enzyme-Linked Immunosorbent Assay

 

RAPID

Immunochromatog- raphy

 

CLIA

Chemiluminescence Immunoassay

 

IFA

Indirect Immunofluorescence Assay

 

IHC

Immunohistochemistry

 

PCR

Polymerase Chain Reaction

 

SEROLOGY

Test Kits

 

VET

Veterinary Test Kits

 

WIDE VARIETY OF

Test Systems

Our extensive Test System portfolio includes ELISA assays, Rapid tests, chemiluminescence assays, Serology tests, IFA test systems, Veterinary tests and instrumentation available to laboratories, Hospitals, Research Institutes and distributors worldwide.

  • ALLERGY
  • ANEMIA
  • AUTOIMMUNE DISEASE
  • BONE METABOLISM
  • CARDIAC MARKERS
  • DIABETES
  • DRUG OF ABUSE
  • FERTILITY
  • FOOD
  • HEPATITIS TESTS
  • INFECTIOUS DISEASE
  • NEONATAL
  • PARASITOLOGY
  • STEROIDS
  • THYROID
  • TUMOR MARKERS

LATEST GROUNDBREAKING PROJECT

HPV+STI Detection Through NGS

Monocent tireless innovation and collaborative work with talented developers and research companies, brings novel solutions to the IVD industry.

One of the most recent projects that Monocent has had the honor of being part of and be instrumental in its validation has to do with revolutionizing HPV and STI detection through Next-Generation Sequencing (NGS) Technology.

Through this method you have the ability to detect 27 HPVs and 13 STIs in one single reaction with a simple workflow. The accuracy and volume of information that this technology can provide, puts it ahead of all its competition. And given its low cost to setup and operate, this technology is the obvious choice for any medium to large size lab.

If you’re interested and like to be involved click below.

9
Subsidiaries
600
Test Kits
30
Countries
80
Distributors